These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 739933)

  • 1. Control of oral anticoagulants by the prothrombin time: a plea for uniformity.
    Bain B; Forster T; Sleigh B
    Med J Aust; 1978 Nov; 2(10):459-61. PubMed ID: 739933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of thromboplastins using the ISI and INR system.
    Moriarty HT; Lam-Po-Tang PR; Anastas N
    Pathology; 1990 Apr; 22(2):71-6. PubMed ID: 2235100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The calibration of rabbit tissue thromboplastins: experience of the Dutch Reference Laboratory for anticoagulant control.
    van den Besselaar AM; Hermans J; van der Velde EA; Bussemaker-Verduyn den Boer E; van Halem-Visser LP; Jansen-Grüter R; Loeliger EA
    J Biol Stand; 1986 Oct; 14(4):305-17. PubMed ID: 3558415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of reference plasmas in the control of oral anticoagulant therapy.
    Miale JB
    Scand J Haematol Suppl; 1980; 37():21-33. PubMed ID: 6941439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of the treatment with oral anticoagulants and prothrombin time].
    Marzouka E
    Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of thromboplastins used for oral anticoagulant control.
    Exner T; Rickard KA; Kronenberg H
    Pathology; 1980 Oct; 12(4):559-66. PubMed ID: 7465252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of instruments for prothrombin time testing on the international normalized ratio.
    Poggio M
    Ric Clin Lab; 1990; 20(1):71-4. PubMed ID: 2356407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
    Guglielmone HA; Vides MA
    Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of the prothrombin time in oral anticoagulant control.
    van den Besselaar AM
    Haemostasis; 1985; 15(4):271-7. PubMed ID: 4043828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical study monitoring low-intensity anticoagulant therapy with a standard-sensitivity thromboplastin.
    Brophy MT; Fiore LD; Lau J; Headley E; Allen M; Deykin D
    Arch Pathol Lab Med; 1993 Jun; 117(6):618-21. PubMed ID: 8503734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
    Loeliger EA; van den Besselaar AM; Lewis SM
    Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboplastin and oral anticoagulant control.
    Lewis SM
    Br J Haematol; 1987 May; 66(1):1-4. PubMed ID: 3593643
    [No Abstract]   [Full Text] [Related]  

  • 14. Prothrombin time standardization: report of the expert panel on oral anticoagulant control. The International Committee on Thrombosis and Haemostasis, The International Committee for Standardization in Hematology.
    Thromb Haemost; 1979 Dec; 42(4):1073-114. PubMed ID: 542923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International normalized ratio in the control of oral anticoagulant therapy.
    Denson KW
    Br J Haematol; 1995 Mar; 89(3):683-4. PubMed ID: 7734382
    [No Abstract]   [Full Text] [Related]  

  • 16. Intensity of oral anticoagulation in patients monitored with various thromboplastins.
    N Engl J Med; 1983 May; 308(20):1228-9. PubMed ID: 6843603
    [No Abstract]   [Full Text] [Related]  

  • 17. ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Loeliger EA
    Acta Haematol; 1984; 72(6):405-7. PubMed ID: 6442525
    [No Abstract]   [Full Text] [Related]  

  • 18. Prothrombin times: an evaluation of four thromboplastins and four machines.
    Starr H; Rhoades P; Lam-Po-Tang PR; Archer GT
    Pathology; 1980 Oct; 12(4):567-74. PubMed ID: 7465253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
    [No Abstract]   [Full Text] [Related]  

  • 20. The optimal therapeutic range in oral anticoagulation. History and proposal.
    Loeliger EA
    Thromb Haemost; 1979 Dec; 42(4):1141-52. PubMed ID: 396691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.